127 related articles for article (PubMed ID: 38914626)
1. Differential impact of COVID-19 non-pharmaceutical interventions on the epidemiological dynamics of respiratory syncytial virus subtypes A and B.
Holmdahl I; Bents SJ; Baker RE; Casalegno JS; Trovão NS; Park SW; Metcalf JE; Viboud C; Grenfell B
Sci Rep; 2024 Jun; 14(1):14527. PubMed ID: 38914626
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Nonpharmaceutical Interventions Implemented in Response to the COVID-19 Pandemic on Seasonal Respiratory Syncytial Virus: Analysis of Google Trends Data.
Ravkin HD; Yom-Tov E; Nesher L
J Med Internet Res; 2022 Dec; 24(12):e42781. PubMed ID: 36476385
[TBL] [Abstract][Full Text] [Related]
3. Respiratory Syncytial Virus Outbreaks Are Predicted after the COVID-19 Pandemic in Tokyo, Japan.
Madaniyazi L; Seposo X; Ng CFS; Tobias A; Toizumi M; Moriuchi H; Yoshida LM; Hashizume M
Jpn J Infect Dis; 2022 Mar; 75(2):209-211. PubMed ID: 34470964
[TBL] [Abstract][Full Text] [Related]
4. In-Depth Analysis of the Re-Emergence of Respiratory Syncytial Virus at a Tertiary Care Hospital in Germany in the Summer of 2021 after the Alleviation of Non-Pharmaceutical Interventions Due to the SARS-CoV-2 Pandemic.
Hönemann M; Thiem S; Bergs S; Berthold T; Propach C; Siekmeyer M; Frille A; Wallborn T; Maier M; Pietsch C
Viruses; 2023 Mar; 15(4):. PubMed ID: 37112857
[TBL] [Abstract][Full Text] [Related]
5. Sequence analysis of respiratory syncytial virus cases reveals a novel subgroup -B strain circulating in north-central Italy after pandemic restrictions.
Pierangeli A; Midulla F; Piralla A; Ferrari G; Nenna R; Pitrolo AMG; Licari A; Marseglia GL; Abruzzese D; Pellegrinelli L; Galli C; Binda S; Cereda D; Fracella M; Oliveto G; Campagna R; Petrarca L; Pariani E; Antonelli G; Baldanti F
J Clin Virol; 2024 Aug; 173():105681. PubMed ID: 38733664
[TBL] [Abstract][Full Text] [Related]
6. Impact of Nonpharmaceutical Interventions during the COVID-19 Pandemic on the Prevalence of Respiratory Syncytial Virus in Hospitalized Children with Lower Respiratory Tract Infections: A Systematic Review and Meta-Analysis.
Leija-Martínez JJ; Esparza-Miranda LA; Rivera-Alfaro G; Noyola DE
Viruses; 2024 Mar; 16(3):. PubMed ID: 38543794
[TBL] [Abstract][Full Text] [Related]
7. Impact of COVID-19 Nonpharmaceutical Interventions on Respiratory Syncytial Virus Infections in Hospitalized Children.
Lu Y; Chen Q; Ren S; Zhang Y; Yi L; Qian C; Shen J; Liu X; Jiang M; Wang B; Song J; Shao X; Zhang T; Tian J; Zhao G
Influenza Other Respir Viruses; 2024 Apr; 18(4):e13291. PubMed ID: 38653953
[TBL] [Abstract][Full Text] [Related]
8. Impact of COVID-19 Pandemic Restrictions on Respiratory Virus Patterns: Insights from RSV Surveillance in Gwangju, South Korea.
Cho SJ; Kim SH; Mun J; Yun JE; Park S; Park J; Lee YU; Park JS; Yun H; Lee CM; Kim JP; Seo JM
Viruses; 2024 May; 16(6):. PubMed ID: 38932143
[TBL] [Abstract][Full Text] [Related]
9. Modeling the impact of COVID-19 nonpharmaceutical interventions on respiratory syncytial virus transmission in South Africa.
Bents SJ; Viboud C; Grenfell BT; Hogan AB; Tempia S; von Gottberg A; Moyes J; Walaza S; Hansen C; Cohen C; Baker RE
Influenza Other Respir Viruses; 2023 Dec; 17(12):e13229. PubMed ID: 38090227
[TBL] [Abstract][Full Text] [Related]
10. Changes in endemic patterns of respiratory syncytial virus infection in pediatric patients under the pressure of nonpharmaceutical interventions for COVID-19 in Beijing, China.
Jiang ML; Xu YP; Wu H; Zhu RN; Sun Y; Chen DM; Wang F; Zhou YT; Guo Q; Wu A; Qian Y; Zhou HY; Zhao LQ
J Med Virol; 2023 Jan; 95(1):e28411. PubMed ID: 36524893
[TBL] [Abstract][Full Text] [Related]
11. RSV through the COVID-19 pandemic: Burden, shifting epidemiology, and implications for the future.
Stein RT; Zar HJ
Pediatr Pulmonol; 2023 Jun; 58(6):1631-1639. PubMed ID: 36811330
[TBL] [Abstract][Full Text] [Related]
12. Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19.
Rice E; Oakes DB; Holland C; Moore HC; Blyth CC
Curr Opin Infect Dis; 2023 Dec; 36(6):522-528. PubMed ID: 37830952
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological characteristics of respiratory viruses in hospitalized children during the COVID-19 pandemic in southwestern China.
Zhu L; Luo T; Yuan Y; Yang S; Niu C; Gong T; Wang X; Xie X; Luo J; Liu E; Fu Z; Tian D
Front Cell Infect Microbiol; 2023; 13():1142199. PubMed ID: 37153160
[TBL] [Abstract][Full Text] [Related]
14. Identifying the impact of non-pharmaceutical interventions on RSV transmission in a single-centre observational study.
Betts TA; Darby AE; Hussain F; Edwards M
BMJ Paediatr Open; 2024 Jun; 8(1):. PubMed ID: 38897622
[TBL] [Abstract][Full Text] [Related]
15. Respiratory syncytial virus incidence and typing in the last six seasons in the north of Spain (Asturias). Genetic characterization during the SARS-CoV-2 pandemic.
Rojo-Alba S; Martínez ZP; González-Alba JM; Boga JA; Varela CO; Álvarez MAA; Fonseca CP; Clemente MMG; Rodriguez JG; García EG; Pérez MR; García SM; Álvarez-Argüelles ME
J Med Virol; 2024 Mar; 96(3):e29499. PubMed ID: 38469919
[TBL] [Abstract][Full Text] [Related]
16. Effects of public health measures during the SARS-CoV-2 pandemic on the winter respiratory syncytial virus epidemic: An interrupted time series analysis.
Reyes Domínguez AI; Pavlovic Nesic S; Urquía Martí L; Pérez González MDC; Reyes Suárez D; García-Muñoz Rodrigo F
Paediatr Perinat Epidemiol; 2022 May; 36(3):329-336. PubMed ID: 34981845
[TBL] [Abstract][Full Text] [Related]
17. Global patterns of rebound to normal RSV dynamics following COVID-19 suppression.
Thindwa D; Li K; Cooper-Wootton D; Zheng Z; Pitzer VE; Weinberger DM
BMC Infect Dis; 2024 Jun; 24(1):635. PubMed ID: 38918718
[TBL] [Abstract][Full Text] [Related]
18. International changes in respiratory syncytial virus (RSV) epidemiology during the COVID-19 pandemic: Association with school closures.
Billard MN; van de Ven PM; Baraldi B; Kragten-Tabatabaie L; Bont LJ; Wildenbeest JG
Influenza Other Respir Viruses; 2022 Sep; 16(5):926-936. PubMed ID: 35733362
[TBL] [Abstract][Full Text] [Related]
19. The Changing Detection Rate of Respiratory Syncytial Virus in Adults in Western Australia between 2017 and 2023.
Foley DA; Minney-Smith CA; Tjea A; Nicol MP; Levy A; Moore HC; Blyth CC
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793538
[TBL] [Abstract][Full Text] [Related]
20. Impact of public health measures and new introducing variants on Respiratory syncytial virus recrudescence in Taiwan during the COVID-19 pandemic.
Lee CY; Wu TH; Fang YP; Chang JC; Wang HC; Lin SJ; Mai CH; Chang YC
J Clin Virol; 2023 Sep; 166():105531. PubMed ID: 37473610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
